Open AccessCutaneous and rheumatological manifestations of reactive arthritis: A case report
Author(s) -
Slouma Maroua,
Ben Dhia Siwar,
Dhahri Rim,
Litaiem Noureddine,
Metoui Leila,
Gharsallah Imen,
Louzir Bassem
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6542
Subject(s) - medicine , reactive arthritis , sulfasalazine , dactylitis , psoriatic arthritis , hla b27 , sacroiliitis , dermatology , arthritis , syphilis , polyarthritis , chlamydia trachomatis , urethritis , chlamydia , sacroiliac joint , immunology , pathology , surgery , enthesitis , antigen , ulcerative colitis , disease , human immunodeficiency virus (hiv) , human leukocyte antigen
Abstract Reactive arthritis is a rare form of spondyloarthropathies occurring after genital or enteric infection. It is most often self‐limited but can progress to chronic spondylarthritis. We report the case of a 30‐year‐old man who presented with acute arthritis occurring 2 months after an episode of urethral discharge. Physical examination revealed polyarthritis, dactylitis, sacroiliac joint involvement, and plantar papulosquamous plaques. The human leukocyte antigen B27 was positive. Detection of Chlamydia trachomatis and Gonococcus in the first catch urine specimen was negative. Hepatitis B and C, Chlamydia trachomatis , human immunodeficiency virus, and syphilis serologic test results were negative. Pelvic magnetic resonance imaging revealed left sacroiliitis. The patient was treated with antibiotics, diclofenac, and sulfasalazine. After 6 months of follow‐up, a significant clinical improvement was obtained without remission, suggesting an evolution to chronic spondylarthritis. Diagnosis of Reactive arthritis is difficult since microbiologic examinations are commonly negative. This disease should be considered in patients with rheumatologic manifestations occurring after a urogenital or enteric infection, mainly when associated with skin manifestations and human leukocyte antigen B27.